A second chance at life: NHS to trial revolutionary treatment for end-stage liver disease

Imagine a world where a failing liver doesn't automatically mean a desperate wait for a transplant. That future might be closer than we think.

The National Health Service (NHS) has greenlit a major trial for a "game-changing" device that acts like a dialysis machine, but for your liver.

Known as Dialive, this tech is being tested across 13 major hospitals to see if it can save patients from Acute-on-Chronic Liver Failure (ACLF), a condition so aggressive that many don't even know they have it until they’re in intensive care.

How does it work?

Think of it as a high-tech spring clean for your blood. When the liver fails, it stops producing healthy proteins and starts letting toxins build up. Dialive uses a dual-filter system to swap out "corrupted" proteins with fresh ones and scrub away the toxins that cause vital organs to shut down.

More from Health

"Many patients die because their bodies become trapped in a destructive cycle of inflammation that current treatments can't reverse," explained Dr Rohit Saha, a consultant at the Royal Free Hospital, who spoke to the Guardian. "Dialive offers new hope, with the potential to put this condition into remission and, for the first time in decades, give us a new path forward," he added.

Why the excitement?

Liver disease is often a silent killer linked to alcohol, obesity, and hepatitis. Currently, three out of four people aren't diagnosed until it’s a life-or-death emergency. Early tests have been incredibly promising: in a smaller study, the device reversed liver failure in twice as many patients compared to standard care.

Professor Rajiv Jalan, the UCL scientist who spent years developing the machine, told the Guardian that the results are an "emotional moment" after decades of research. "The liver has an incredible potential to regenerate," he said. "If we can keep the patient alive and clear the environment for regeneration to happen, we should be able to bridge many of these patients to recovery."

What’s next?

Starting early next year, 72 of the sickest patients will join this government-funded trial. If it works, Dialive could become the world’s first successful form of liver dialysis, a literal lifesaver that could keep thousands of people off the transplant list and get them back to their families.